AngioDynamics Reports Fiscal 2016 Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
UPDATE: AngioDynamics (ANGO) Tops Q3 EPS by 1c; Cuts FY EPS Outlook
April 7, 2016 4:02 PM EDT(Updated - April 7, 2016 4:04 PM EDT)
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.15, $0.01 better than the analyst estimate of $0.14. Revenue for the quarter came in at $87.4 million versus the consensus estimate of $85.07 million.
The company sees FY15 EPS of $0.54 - $0.58, from $0.59 -... More
